DE LERMA BARBARO, ANDREA
DE LERMA BARBARO, ANDREA
DIPARTIMENTO DI BIOTECNOLOGIE E SCIENZE DELLA VITA
A new strategy of tumor vaccination based on mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA
2005-01-01 Mortara, Lorenzo; Castellani, P.; Meazza, R.; Tosi, Giovanna; DE LERMA BARBARO, Andrea; Procopio, F.; Zardi, L.; Ferrini, S.; Accolla, Roberto
A new strategy of tumor vaccination based on tumor cells transduced with the MHC class II transactivator CIITA
2005-01-01 Mortara, Lorenzo; Castellani, P.; Meazza, R.; Tosi, Giovanna; DE LERMA BARBARO, Andrea; Procopio, F. A.; Zardi, L.; Ferrini, S.; Accolla, Roberto
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells
1996-01-01 Sartoris, S; Tosi, Giovanna; DE LERMA BARBARO, Andrea; Cestari, T; Accolla, Roberto
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
1996-01-01 Sartoris, S; Tosi, G; DE LERMA BARBARO, A; Cestari, T; Accolla, Roberto
Analysis of a combined immunodeficiency patient with defect in MHCII expression (BLS) reveals the presence of several mutant isoforms of RFXANK mRNA
2005-01-01 Tosi, Giovanna; Murgia, B.; DE LERMA BARBARO, Andrea; Procopio, F.; Mortara, Lorenzo; Soresina, A. R.; Meini, A.; Plebani, A.; Accolla, Roberto
Analysis of microchimerism in thyroid autoimmune diseases
2005-01-01 Procopio, F. A.; DE LERMA BARBARO, Andrea; Tosi, Giovanna; Grasso, L.; Basolo, F.; Sessa, Fausto; Bartalena, Luigi; Accolla, Roberto
Antitumor vaccines and immunotherapeutic strategies based on CIITA-driven MHC class II espression in cancer cells.
2010-01-01 Mortara, Lorenzo; V., Frangione; Capone, Giacomo; P., Castellani; DE LERMA BARBARO, Andrea; Accolla, Roberto
Apoptotic DNA binds to HLA class II molecules inhibiting antigen presentation and partecipatine in the development of anti-inflammatory functional behavior of phagocytic macrophages
2003-01-01 Filaci, G.; Contini, P.; Fravega, M.; Fenoglio, D.; Azzarone, B.; JULIEN GIRON, M.; Fiocca, R.; Boggio, M.; Necchi, V.; DE LERMA BARBARO, Andrea; Merlo, A.; Rizzi, M.; Ghio, M.; Setti, M.; Puppo, F.; Zanetti, M.; Indiveri, F.
Block of Stat-1 activation in macrophages, undergoing bacterial phagocytosis causes CIITA reduced transcription and consequent impaired antigen presentation
2002-01-01 DE LERMA BARBARO, Andrea; Tosi, Giovanna; Frumento, G.; Bruschi, E.; D'Agostino, A.; Valle, M. T.; Manca, F.; Accolla, Roberto
Characterization of an epigenetic variant lacking MHC-II inducibility by IFN-g in the promyelocytic cell line THP-1
2006-01-01 DE LERMA BARBARO, Andrea; A., DE AMBROSIS; O., Aresu; F. A., Procopio; Mortara, Lorenzo; Tosi, Giovanna; B., Parodi; S., Ferrini; Accolla, Roberto
CIITA blocks the function of HIV-1 Tat by competing for cyclin T1 and inhibits viral replication
2002-01-01 Accolla, Roberto; Mazza, S.; DE LERMA BARBARO, Andrea; Tosi, Giovanna
CIITA reduced transcription as the cause of HLA class II down-modulation in human macrophages during bacterial phagocytosis
2000-01-01 DE LERMA BARBARO, Andrea; Tosi, Giovanna; G., Frumento; E., Bruschi; A., D’Agostino; M. T., Valle; F., Manca; Accolla, Roberto
CIITA reduced transcription as the cause of HLA class II downregulation in human macrophages during bacterial phagocytosis
2000-01-01 DE LERMA BARBARO, Andrea; Tosi, G.; Frumento, G.; Bruschi, E.; D, ; Agostino, A.; Valle, M. T.; Manca, F.; Accolla, Roberto
CIITA-driven MHC class II expressing tumor cells of distinct hystotype act as a potent antitumor vaccine and as a superior generators of tumor-specific CD4+ T lymphocytes for immunotherapy.
2010-01-01 Mortara, Lorenzo; V., Frangione; Capone, Giacomo; P., Castellani; DE LERMA BARBARO, Andrea; Accolla, Roberto
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy
2010-01-01 Frangione, V; Mortara, Lorenzo; Castellani, P; DE LERMA BARBARO, Andrea; Accolla, Roberto
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4+ T lymphocytes for immunotherapy
2010-01-01 Frangione, V.; Mortara, L.; Castellani, P.; De Lerma Barbaro, A.; Accolla, R.
CIITA-driven MHC-II+ tumor cells: preventive vaccines and superior generators of anti-tumor CD4+ T lymphocytes for immunotherapy.
2010-01-01 Mortara, Lorenzo; V., Frangione; P., Castellani; Capone, Giacomo; DE LERMA BARBARO, Andrea; Accolla, Roberto
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.
2006-01-01 Accolla, Roberto; Tosi, Giovanna; DE LERMA BARBARO, Andrea; P., Castellani; S., Ferrini; L., Zardi; Mortara, Lorenzo
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory
2010-01-01 Mortara, Lorenzo; Castellani, P.; Meazza, R.; Tosi, Giovanna; DE LERMA BARBARO, Andrea; Procopio, F. A.; Comes, A.; Zardi, L.; Ferrini, S.; Accolla, Roberto
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory
2006-01-01 Mortara, Lorenzo; Castellani, P; Meazza, R; Tosi, Giovanna; DE LERMA BARBARO, Andrea; Procopio, Fa; Comes, A; Zardi, L; Ferrini, S; Accolla, Roberto